lobbying_activities: 2197200

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2197200	c4cd9a44-dffa-4dfa-90ca-3e2dba7e18f1	Q3	OREGON HEALTH & SCIENCE UNIVERSITY	30291	OREGON HEALTH & SCIENCE UNIVERSITY	2018	third_quarter	BUD	FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; H.R. 3358/S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2018; H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96); H.R. 1892, Bipartisan Budget Act of 2018 (P.L. 115-123); H.R. 1625, Consolidated Appropriations Act, 2018 (P.L. 115-141); H.R. 6470/ S. 3158, departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R. 5961/S. 2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2019; H.R. 6157, Department of Defense and Labor, Health and Human Services, and education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L.115-245); Health and science related funding issues.	HOUSE OF REPRESENTATIVES,SENATE		80000	0	0	2018-10-19T14:08:49.523000-04:00